MYO logo

MYOMO INC

MYONYSE AMERICAN
๐Ÿ† #4356 by market capUS Equity
โ€”โ€”
Quote unavailable
๐Ÿ””
Track MYO
Get earnings, price moves & breaking news on Telegram
Track
24hโ€”
7dโ€”
14dโ€”
30dโ€”
ytdโ€”
1yโ€”
๐ŸฆMarket Cap
$33M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
6.1%
Slowing
๐Ÿ“ŠGross Margin
68.3%
High
๐Ÿ’ตFCF Margin
โ€”
โš–๏ธP/S Ratio
0.8x
Cheap
Otter Score
โ€”
Insufficient data
No chart data available for MYO.

Trading Snapshot

Day Range
โ€”
52-Week Range
$0.61 โ€“ $1.89
Volume (shares)
โ€”
Avg Volume (shares)
โ€”
Shares Outstanding
39.6M
Next Earnings
โ€”

Fundamentals Snapshot

Annual Revenue
โ€”
Last Q Revenue
โ€”
P/E Ratio
โ€”
P/S Ratio
0.8x
EPS (TTM)
$-0.34
Dividend Yield
โ€”
MYO logo

MYOMO INC

MYO
Financial Trends

Financial history unavailable.

StockOtter ยท stockotter.space

About MYOMO INC

Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.